Henry Schein to Webcast Third Quarter 2024 Conference Call on Tuesday, November 5, 2024 at 10:00 a.m. ET
01 Octubre 2024 - 5:30AM
Business Wire
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider
of health care solutions to office-based dental and medical
practitioners, announced today that it will release its third
quarter 2024 financial results before the stock market opens on
Tuesday, November 5, 2024, and will provide a live webcast of its
earnings conference call on the same day beginning at 10:00 a.m.
Eastern time.
Speakers on the call will include Stanley M. Bergman, Chairman
of the Board and Chief Executive Officer of Henry Schein, and
Ronald N. South, Senior Vice President and Chief Financial
Officer.
Investors can access the call by visiting
https://investor.henryschein.com/webcasts. A replay will be
available on the Henry Schein website following the
presentation.
Cautionary Note Regarding Forward-Looking Statements
In accordance with the “Safe Harbor” provisions of the Private
Securities Litigation Reform Act of 1995, we provide the following
cautionary remarks regarding important factors that, among others,
could cause future results to differ materially from the
forward-looking statements, expectations and assumptions expressed
or implied herein. All forward-looking statements made by us are
subject to risks and uncertainties and are not guarantees of future
performance. These forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause our
actual results, performance and achievements or industry results to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. These statements include EPS and Adjusted EBITDA
guidance and are generally identified by the use of such terms as
“may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,”
“forecast,” “project,” “anticipate,” “to be,” “to make” or other
comparable terms. A fuller discussion of our operations, financial
condition and status of litigation matters, including factors that
may affect our business and future prospects, is contained in
documents we have filed with the United States Securities and
Exchange Commission, or SEC, including our Annual Report on Form
10-K, and will be contained in all subsequent periodic filings we
make with the SEC. These documents identify in detail important
risk factors that could cause our actual performance to differ
materially from current expectations.
Risk factors and uncertainties that could cause actual results
to differ materially from current and historical results include,
but are not limited to: our dependence on third parties for the
manufacture and supply of our products; our ability to develop or
acquire and maintain and protect new products (particularly
technology products) and technologies that achieve market
acceptance with acceptable margins; transitional challenges
associated with acquisitions, dispositions and joint ventures,
including the failure to achieve anticipated synergies/benefits, as
well as significant demands on our operations, information systems,
legal, regulatory, compliance, , financial and human resources
functions in connection with acquisitions, dispositions and joint
ventures; certain provisions in our governing documents that may
discourage third-party acquisitions of us; adverse changes in
supplier rebates or other purchasing incentives; risks related to
the sale of corporate brand products; security risks associated
with our information systems and technology products and services,
such as cyberattacks or other privacy or data security breaches
(including the October 2023 incident); effects of a highly
competitive (including, without limitation, competition from
third-party online commerce sites) and consolidating market;
changes in the health care industry; risks from expansion of
customer purchasing power and multi-tiered costing structures;
increases in shipping costs for our products or other service
issues with our third-party shippers; general global and domestic
macro-economic and political conditions, including inflation,
deflation, recession, ongoing wars, fluctuations in energy pricing
and the value of the U.S. dollar as compared to foreign currencies,
and changes to other economic indicators, international trade
agreements, potential trade barriers and terrorism; geopolitical
wars; failure to comply with existing and future regulatory
requirements; risks associated with the EU Medical Device
Regulation; failure to comply with laws and regulations relating to
health care fraud or other laws and regulations; failure to comply
with laws and regulations relating to the collection, storage and
processing of sensitive personal information or standards in
electronic health records or transmissions; changes in tax
legislation; risks related to product liability, intellectual
property and other claims; risks associated with customs policies
or legislative import restrictions; risks associated with disease
outbreaks, epidemics, pandemics (such as the COVID-19 pandemic), or
similar wide-spread public health concerns and other natural or
man-made disasters; risks associated with our global operations;
litigation risks; new or unanticipated litigation developments and
the status of litigation matters; our dependence on our senior
management, employee hiring and retention, and our relationships
with customers, suppliers and manufacturers; and disruptions in
financial markets. The order in which these factors appear should
not be construed to indicate their relative importance or
priority.
We caution that these factors may not be exhaustive and that
many of these factors are beyond our ability to control or predict.
Accordingly, any forward-looking statements contained herein should
not be relied upon as a prediction of actual results. We undertake
no duty and have no obligation to update forward-looking statements
except as required by law.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for
health care professionals powered by a network of people and
technology. With more than 25,000 Team Schein Members worldwide,
the Company's network of trusted advisors provides more than 1
million customers globally with more than 300 valued solutions that
help improve operational success and clinical outcomes. Our
Business, Clinical, Technology, and Supply Chain solutions help
office-based dental and medical practitioners work more efficiently
so they can provide quality care more effectively. These solutions
also support dental laboratories, government and institutional
health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated
distribution network, with a selection of more than 300,000 branded
products and Henry Schein corporate brand products in our main
distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index,
Henry Schein is headquartered in Melville, N.Y., and has operations
or affiliates in 33 countries and territories. The Company's sales
reached $12.3 billion in 2023, and have grown at a compound annual
rate of approximately 11.5 percent since Henry Schein became a
public company in 1995.
For more information, visit Henry Schein at www.henryschein.com,
Facebook.com/HenrySchein, and @HenrySchein on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240927067515/en/
Investors Ronald N. South Senior
Vice President and Chief Financial Officer
ronald.south@henryschein.com (631) 843-5500
Graham Stanley Vice President, Investor Relations and Strategic
Finance Project Officer graham.stanley@henryschein.com (631)
843-5500
Media Ann Marie Gothard Vice
President, Global Corporate Media Relations
annmarie.gothard@henryschein.com (631) 390-8169
Henry Schein (NASDAQ:HSIC)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Henry Schein (NASDAQ:HSIC)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024